Application Note: Micro-Formulation For Intravenous Injection
Source: Cirrus Pharmaceuticals, Inc.
The purpose of this work was to develop methodologies for formulating new chemical entities (NCEs) for intravenous injection using only a few milligrams of the NCE. This "micro-formulation" approach was developed to facilitate in vivo screening of drug candidates at an early stage of development, when many NCEs may be under consideration and very little of each may be available. Submitted by Cirrus Pharmaceuticals
access the Application Note!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more